Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M606144200 on December 4, 2006

J. Biol. Chem., Vol. 282, Issue 5, 2929-2936, February 2, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/5/2929    most recent
M606144200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krejci, P.
Right arrow Articles by Wilcox, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krejci, P.
Right arrow Articles by Wilcox, W. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Bisindolylmaleimide I Suppresses Fibroblast Growth Factor-mediated Activation of Erk MAP Kinase in Chondrocytes by Preventing Shp2 Association with the Frs2 and Gab1 Adaptor Proteins*

Pavel Krejci{ddagger}1, Bernard Masri§, Lisa Salazar, Claire Farrington-Rock{ddagger}, Herve Prats§, Leslie Michels Thompson, and William R. Wilcox{ddagger}||

From the {ddagger}Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, the §INSERM U589, Institut Louis Bugnard, 31403 Toulouse, France, the Department of Psychiatry, University of California, Irvine, California 92697, and the ||Department of Pediatrics, UCLA School of Medicine, Los Angeles, California 90095

Fibroblast growth factors (FGFs) inhibit chondrocyte proliferation via the Erk MAP kinase pathway. Here, we explored the role of protein kinase C in FGF signaling in chondrocytes. Erk activity in FGF2-treated RCS (rat chondrosarcoma) chondrocytes or human primary chondrocytes was abolished by the protein kinase C inhibitor bisindolylmaleimide I (Bis I). Bis I inhibited FGF2-induced activation of MEK, Raf-1, and Ras members of Erk signaling module but not the FGF2-induced tyrosine phosphorylation of Frs2 or the kinase activity of FGFR3, demonstrating that it targets the Erk cascade immediately upstream of Ras. Indeed, Bis I abolished the FGF2-mediated association of Shp2 tyrosine phosphatase with Frs2 and Gab1 adaptor proteins necessary for proper Ras activation. We also determined which PKC isoform is involved in FGF2-mediated activation of Erk. When both conventional and novel PKCs expressed by RCS chondrocytes (PKC{alpha}, -{gamma}, -{delta}, and -{epsilon}) were down-regulated by phorbol ester, cells remained responsive to FGF2 with Erk activation, and this activation was sensitive to Bis I. Moreover, treatment with PKC{lambda}/{zeta} pseudosubstrate lead to significant reduction of FGF2-mediated activation of Erk, suggesting involvement of an atypical PKC.


Received for publication, June 27, 2006 , and in revised form, November 7, 2006.

* This work was supported by the Yang Sheng Tang USA Co. and by National Institutes of Health Grant 5P01-HD22657. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Medical Genetics Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd., SSB-3, Los Angeles, CA 90048. Tel.: 310-423-4971; Fax: 310-423-0620; E-mail: pavel.krejci{at}cshs.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
L. Salazar, T. Kashiwada, P. Krejci, P. Muchowski, D. Donoghue, W. R. Wilcox, and L. M. Thompson
A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells
Hum. Mol. Genet., June 1, 2009; 18(11): 1951 - 1961.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
S. S. Jump, T. E. Childs, K. A. Zwetsloot, F. W. Booth, and S. J. Lees
Fibroblast growth factor 2-stimulated proliferation is lower in muscle precursor cells from old rats
Exp Physiol, June 1, 2009; 94(6): 739 - 748.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Matsushita, W. R. Wilcox, Y. Y. Chan, A. Kawanami, H. Bukulmez, G. Balmes, P. Krejci, P. B. Mekikian, K. Otani, I. Yamaura, et al.
FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway
Hum. Mol. Genet., January 15, 2009; 18(2): 227 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Krejci, L. Salazar, H. S. Goodridge, T. A. Kashiwada, M. J. Schibler, P. Jelinkova, L. M. Thompson, and W. R. Wilcox
STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
J. Cell Sci., February 1, 2008; 121(3): 272 - 281.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement